Ultra High-Volume Scanners

PRODUCTS

  • Addressing Modern mAb Purification Challenges

    The latest protein A resin from Purolite, an Ecolab company, DurA Cycle A50 aims to maximize productivity and improve process economics.

    DurA Cycle A50 improves purification performance with high capacities, which can help to enable a lower cost per gram of commercial drug product. Building on the innovation of Praesto™ Jetted A50 HipH, DurA Cycle A50 provides a wider elution pH window to address aggregate clearance.

  • PHCbi brand’s LabSVIFT® IoT lab management solution is designed to provide real-time visibility and control of laboratory equipment and environments across single or multiple facilities. This cloud-based platform enables centralized monitoring, customizable alerts, and secure data access via a web-based dashboard. The new health check* function continuously evaluates equipment performance, identifies irregularities, and provides recommended corrective actions to maintain optimal operation. The system supports FDA 21 CFR Part 11 compliance and is compatible with select PHCbi and third-party devices. *health check function compatibility varies by model

  • PHCbi brand's 25.3 cu.ft (715L) ultra-low temperature TwinGuard chest freezer features a dual cooling system to offer our highest level of sample protection through the use of two independent refrigeration systems. The combination of these two circuits work together for fast temperature recovery while keeping ultra-low temperatures if one refrigeration system fails to cool. This freezer is ideal for safe, long term storage of your most high valued products, such as stem cells, embryos, cell lines, rare specimens, and other biological materials.

  • Container closure integrity testing (CCIT) is crucial in the pharmaceutical industry to ensure that vials maintain their sterility and product quality throughout their shelf life. These systems are designed to detect any leaks or defects in the vial's seal that could compromise the product.

  • Gain access to Culture bioreactors when you need rapid overflow experimental capacity.

    Benefits

    Progress studies faster

    Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.

    Stay agile in your capacity planning

    Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.

    Eliminate your capital equipment spend

    Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.

WHITE PAPERS AND CASE STUDIES

NEWS